GlaxoSmithKline places its shingles vaccine ... shot in all territories other than BioNTech's home market of Germany, Turkey and certain other developing countries. "Adults aged 50 years and ...

Astellas also has rights to the drug in Japan – where it also approved and on sale – as well as Turkey, Russia ... has provided an opportunity for GSK and Akebia to beat FibroGen and AZ ...

European stocks plunged sharply, and several markets tumbled to fresh multi-month lows on Friday as US President Donald Trump’s sweeping tariff moves, and the retaliatory action by China raised fears ...

Washington University’s Olin Business School BIG IdeaBounce competition features the business of health The business of ...

Organic growth of 2.1% in Q1 2025, in line with full-year guidance Growth of 5.2% as reported, reflecting the positive impact of recent acquisitions and currency effects 2025 full-year ...

PRESIDENT Donald Trump has insisted the US is already bringing in $2 billion per day due to his sweeping global tariffs.

Involves transaction of at least 0.5% of the listed shares of a company. What was Glaxosmithkline Pharmaceuticals Ltd share price previously? Glaxosmithkline Pharmaceuticals Ltd share price was up ...

Shoppers browse a Walmart Supercenter a day after U.S. President Donald Trump announced new tariffs, in Secaucus, New Jersey, U.S. April 3, 2025. REUTERS/Siddharth Cavale/File photo U.S. consumer ...

ABL Bio Inc., a South Korean biotech company, will license out its proprietary blood-brain barrier shuttle platform, called the Grabody-B, to UK-based pharmaceutical giant GSK plc in a deal expected ...

At close: April 1 at 4:00:02 PM EDT ...